Colorado Recalls Colorado's Best Dabs Concentrate Over Contamination

Recall Scope and Product Details

The recall targets concentrate products sold under the Colorado's Best Dabs brand, a label used by multiple licensed processors across the state. Colorado's regulatory framework allows brand licensing across facilities, complicating traceability when a recall spans multiple production sites. The Marijuana Enforcement Division hasn't released batch numbers, production dates, or the names of the manufacturing facilities involved.

Consumers who purchased Colorado's Best Dabs products in recent weeks should check with their dispensary of purchase for guidance on returns or disposal. Most Colorado dispensaries maintain seed-to-sale tracking via METRC, the state's mandatory inventory system. Retailers can identify recalled inventory within hours of a state notice.

Contaminant Type Remains Undisclosed

The MED notice didn't specify whether the violation involved pesticides, heavy metals, microbial contamination, or residual solvents—the four most common failure categories in Colorado's mandatory testing regime. Colorado requires all concentrate products to pass testing for:

• Pesticide residues (action levels set by the Colorado Department of Public Health and Environment)
• Heavy metals including lead, arsenic, cadmium, and mercury
• Microbial contaminants (yeast, mold, E. coli, Salmonella)
• Residual solvents (butane, propane, ethanol) for extraction-based concentrates

Failure on any parameter triggers an automatic hold in METRC and a mandatory recall if product has already reached retail. The lack of detail in the MED's public notice follows a pattern seen in other U.S. states, where regulators often cite confidentiality concerns or ongoing investigations.

Colorado's Recall Frequency in Context

Colorado issued 14 product recalls in 2025, down from 22 in 2024, according to MED public notices. The decline reflects tightening of lab-accreditation standards under rules finalized in late 2023, which required all testing labs to achieve ISO/IEC 17025 certification by January 2025. Labs that failed to meet the deadline lost their state licenses, reducing the total number of accredited facilities from 19 to 11.

By comparison, California's Department of Cannabis Control issued 31 recalls in 2025, while Michigan's Cannabis Regulatory Agency logged 18. Recall rates correlate closely with testing-threshold stringency and lab-oversight rigor, not necessarily with product-safety outcomes—a dynamic familiar to regulators in Canada and Germany, where federal oversight of testing protocols reduced recall variance across provinces and Länder.

Operator and Consumer Impact

Recalls impose direct financial losses on cultivators and processors, who bear the cost of destroyed inventory, and on dispensaries, which must pull products mid-sale and process customer refunds. Colorado doesn't maintain a state-funded recall-compensation program, unlike some European medical-cannabis frameworks where governments reimburse licensed operators for qualifying safety recalls.

For consumers, the health risk depends entirely on the undisclosed contaminant. Pesticide exposure from cannabis concentrates has been linked to acute respiratory symptoms in case studies published by the CDC. Heavy-metal contamination poses cumulative toxicity risks with chronic use. The MED hasn't issued guidance on whether consumers who used the recalled product should seek medical evaluation.

What Dispensaries and Consumers Should Do

Dispensaries holding Colorado's Best Dabs inventory must quarantine all units and await disposal instructions from the MED, typically delivered via METRC notifications. Retailers face fines up to $10,000 per violation if they sell product after a recall notice, under Colorado's administrative penalty schedule.

Consumers should:

• Check purchase receipts for the brand name and contact the dispensary for confirmation
• Return unused product to the point of sale for refund or disposal
• Monitor the MED's public-notice page for updated batch information if released
• Report adverse health effects to the Colorado Department of Public Health and Environment's cannabis safety hotline

The MED hasn't indicated whether the recall will trigger a broader compliance audit of the affected manufacturing facilities. We'll be watching for batch-level detail and contaminant disclosure in coming MED updates. For full context on Colorado's testing and recall protocols, see the CannIntel topic hub on Colorado cannabis recalls.